相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)
Kevin Damman et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Empagliflozin in Heart Failure Diuretic and Cardiorenal Effects
Matthew Griffin et al.
CIRCULATION (2020)
Antihypertensive and Renal Mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) Inhibitors
Christopher S. Wilcox
HYPERTENSION (2020)
Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment
Eva M. Boorsma et al.
NATURE REVIEWS CARDIOLOGY (2020)
Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
Alice M. Jackson et al.
CIRCULATION (2020)
Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure The RECEDE-CHF Trial
Natalie A. Mordi et al.
CIRCULATION (2020)
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)
Matteo Serenelli et al.
EUROPEAN HEART JOURNAL (2020)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System Inhibitors
Mie K. Eickhoff et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes
Petter Bjornstad et al.
DIABETES CARE (2018)
Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure
Jorge Rubio-Gracia et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Interaction Between the Sodium-Glucose-Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diuretic Bumetanide in Normal Human Subjects
Christopher S. Wilcox et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial
Christoph Wanner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis
Karen M. Hallow et al.
DIABETES OBESITY & METABOLISM (2018)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications
Hiddo J. L. Heerspink et al.
CIRCULATION (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Insulin and IGF-1 activate Kir4.1/5.1 channels in cortical collecting duct principal cells to control basolateral membrane voltage
Oleg Zaika et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Diuretic response in acute heart failure -pathophysiology, evaluation, and therapy
Jozine M. ter Maaten et al.
NATURE REVIEWS CARDIOLOGY (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
David Z. I. Cherney et al.
CIRCULATION (2014)
Estimating 24-Hour Urinary Sodium Excretion From Casual Urinary Sodium Concentrations in Western Populations
Ian J. Brown et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Regulation of Renal NaCl Transport by Nitric Oxide, Endothelin, and ATP: Clinical Implications
Jeffrey L. Garvin et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
Mechanisms of disease - Aldosterone in congestive heart failure
KT Weber
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
